US3711611A - Composition of matter with low cholesterol content and containing wool grease alcohols as major component and method - Google Patents
Composition of matter with low cholesterol content and containing wool grease alcohols as major component and method Download PDFInfo
- Publication number
- US3711611A US3711611A US00137028A US3711611DA US3711611A US 3711611 A US3711611 A US 3711611A US 00137028 A US00137028 A US 00137028A US 3711611D A US3711611D A US 3711611DA US 3711611 A US3711611 A US 3711611A
- Authority
- US
- United States
- Prior art keywords
- cholesterol
- wool wax
- alcohols
- wax alcohols
- sitosterol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title claims abstract description 129
- 235000012000 cholesterol Nutrition 0.000 title claims abstract description 63
- 239000000203 mixture Substances 0.000 title claims description 34
- 150000001298 alcohols Chemical class 0.000 title claims description 28
- 235000019388 lanolin Nutrition 0.000 title abstract description 30
- 238000000034 method Methods 0.000 title description 8
- 239000004166 Lanolin Substances 0.000 claims abstract description 80
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 claims abstract description 23
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 claims abstract description 23
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229950005143 sitosterol Drugs 0.000 claims abstract description 22
- 239000000839 emulsion Substances 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 235000015500 sitosterol Nutrition 0.000 claims description 25
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 claims description 22
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 claims description 21
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 claims description 21
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 claims description 21
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 claims description 21
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 claims description 21
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 claims description 21
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 239000003784 tall oil Substances 0.000 claims description 8
- 239000002480 mineral oil Substances 0.000 claims description 7
- 239000003963 antioxidant agent Substances 0.000 claims description 6
- 230000003078 antioxidant effect Effects 0.000 claims description 6
- 235000010446 mineral oil Nutrition 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 5
- 239000001993 wax Substances 0.000 claims description 5
- 244000068988 Glycine max Species 0.000 claims description 4
- 235000010469 Glycine max Nutrition 0.000 claims description 4
- 239000008278 cosmetic cream Substances 0.000 claims description 3
- 239000008341 cosmetic lotion Substances 0.000 claims description 3
- 238000004945 emulsification Methods 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 11
- 239000003995 emulsifying agent Substances 0.000 abstract description 5
- 239000002270 dispersing agent Substances 0.000 abstract description 2
- 229940076810 beta sitosterol Drugs 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 description 17
- 229930182558 Sterol Natural products 0.000 description 16
- 235000003702 sterols Nutrition 0.000 description 16
- 150000003432 sterols Chemical class 0.000 description 15
- 239000000047 product Substances 0.000 description 11
- 230000001804 emulsifying effect Effects 0.000 description 8
- 239000006071 cream Substances 0.000 description 6
- 238000000199 molecular distillation Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000000605 extraction Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- LGJMUZUPVCAVPU-ANOYILKDSA-N (3s,8r,9s,10s,13r,14s,17r)-17-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-ol Chemical class C1CC2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@H](CC)C(C)C)[C@@]1(C)CC2 LGJMUZUPVCAVPU-ANOYILKDSA-N 0.000 description 4
- 239000003974 emollient agent Substances 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 238000007127 saponification reaction Methods 0.000 description 4
- 229940083492 sitosterols Drugs 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 210000002268 wool Anatomy 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 235000012343 cottonseed oil Nutrition 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000004519 grease Substances 0.000 description 3
- 239000004973 liquid crystal related substance Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 235000012424 soybean oil Nutrition 0.000 description 3
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000002385 cottonseed oil Substances 0.000 description 2
- 235000004879 dioscorea Nutrition 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- -1 lanosterol Chemical class 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 210000000278 spinal cord Anatomy 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- QIVUCLWGARAQIO-OLIXTKCUSA-N (3s)-n-[(3s,5s,6r)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl]-2-oxospiro[1h-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide Chemical compound C1([C@H]2[C@H](N(C(=O)[C@@H](NC(=O)C=3C=C4C[C@]5(CC4=NC=3)C3=CC=CN=C3NC5=O)C2)CC(F)(F)F)C)=C(F)C=CC(F)=C1F QIVUCLWGARAQIO-OLIXTKCUSA-N 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 244000198134 Agave sisalana Species 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-NRHJOKMGSA-N Brassicasterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@](C)([C@H]([C@@H](/C=C/[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 OILXMJHPFNGGTO-NRHJOKMGSA-N 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 240000006497 Dianthus caryophyllus Species 0.000 description 1
- 235000009355 Dianthus caryophyllus Nutrition 0.000 description 1
- QRLVDLBMBULFAL-UHFFFAOYSA-N Digitonin Natural products CC1CCC2(OC1)OC3C(O)C4C5CCC6CC(OC7OC(CO)C(OC8OC(CO)C(O)C(OC9OCC(O)C(O)C9OC%10OC(CO)C(O)C(OC%11OC(CO)C(O)C(O)C%11O)C%10O)C8O)C(O)C7O)C(O)CC6(C)C5CCC4(C)C3C2C QRLVDLBMBULFAL-UHFFFAOYSA-N 0.000 description 1
- 235000005903 Dioscorea Nutrition 0.000 description 1
- 244000281702 Dioscorea villosa Species 0.000 description 1
- 235000000504 Dioscorea villosa Nutrition 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- QOLRLLFJMZLYQJ-LOBDNJQFSA-N Hecogenin Chemical compound O([C@@H]1[C@@H]([C@]2(C(=O)C[C@@H]3[C@@]4(C)CC[C@H](O)C[C@@H]4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 QOLRLLFJMZLYQJ-LOBDNJQFSA-N 0.000 description 1
- OXLGJTRVVNGJRK-UHFFFAOYSA-N Hecogenin Natural products CC1CCC2(CC3CC4C5CCC6CC(O)CCC6(C)C5CC(=O)C4(C)C3C2C)OC1 OXLGJTRVVNGJRK-UHFFFAOYSA-N 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- UVLDESQWQRMYKD-UHFFFAOYSA-N Neobotogenin Natural products CC1C(C2(C(=O)CC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 UVLDESQWQRMYKD-UHFFFAOYSA-N 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- DWCSNWXARWMZTG-UHFFFAOYSA-N Trigonegenin A Natural products CC1C(C2(CCC3C4(C)CCC(O)C=C4CCC3C2C2)C)C2OC11CCC(C)CO1 DWCSNWXARWMZTG-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-ZRUUVFCLSA-N UNPD197407 Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)C=C[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZRUUVFCLSA-N 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- OILXMJHPFNGGTO-ZAUYPBDWSA-N brassicasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZAUYPBDWSA-N 0.000 description 1
- 235000004420 brassicasterol Nutrition 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 230000001906 cholesterol absorption Effects 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- OWZREIFADZCYQD-NSHGMRRFSA-N deltamethrin Chemical compound CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 OWZREIFADZCYQD-NSHGMRRFSA-N 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- UVYVLBIGDKGWPX-KUAJCENISA-N digitonin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O[C@H]5[C@@H]([C@@H](O)[C@@H](O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)CO7)O)[C@H](O)[C@@H](CO)O6)O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O7)O)[C@@H](O)[C@@H](CO)O6)O)[C@@H](CO)O5)O)C[C@@H]4CC[C@H]3[C@@H]2[C@@H]1O)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 UVYVLBIGDKGWPX-KUAJCENISA-N 0.000 description 1
- UVYVLBIGDKGWPX-UHFFFAOYSA-N digitonine Natural products CC1C(C2(CCC3C4(C)CC(O)C(OC5C(C(O)C(OC6C(C(OC7C(C(O)C(O)CO7)O)C(O)C(CO)O6)OC6C(C(OC7C(C(O)C(O)C(CO)O7)O)C(O)C(CO)O6)O)C(CO)O5)O)CC4CCC3C2C2O)C)C2OC11CCC(C)CO1 UVYVLBIGDKGWPX-UHFFFAOYSA-N 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- WQLVFSAGQJTQCK-VKROHFNGSA-N diosgenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 WQLVFSAGQJTQCK-VKROHFNGSA-N 0.000 description 1
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000006486 human diet Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000010893 paper waste Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000003265 pulping liquor Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 238000009991 scouring Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
- C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
- C09K23/38—Alcohols, e.g. oxidation products of paraffins
Definitions
- ABSTRACT A new and useful dispersing and emulsifying agent derived from wool grease made by separating cholesterol from the unsaponifiables and replacing the cholesterol with Bsitosterol', to form an improved essentially wool wax alcohol product.
- Lanolin a wool grease freed from dirt; deodorized and sometimes bleached.
- Lanolin has become a sine qua non for the cosmetic industry, primarily because of its capacity to absorb water with the formation of emulsions with light minerals oils, and heavy petrolatum, such as Vaseline, etc.
- Wool wax is composed, for the most part, of esters, compounds of alcohols with a variety of fatty acids. Prominent among these alcohols is another useful product, cholesterol, which constitutes as high as 25 to 32 percent of the alcohol fraction of wool grease. Alongside cholesterol, there are other alcohols, such as lanosterol, and lower molecular weight alcohols, some of which are glycols. The alcohol fraction is separated by saponification of the wool grease, and separation of the alcohols from the saponification mixture of free fatty acids and wool wax alcohols.
- Cholesterol has one use for which no other product has been able to supplant it, namely, the synthesis of Vitamin D a vitamin absolutely essential to the life and well-being of all two-footed animals.
- Still another object of this invention is to replace the cholesterol in wool grease by another sterol, equal in stability and contributing essentially the same emulsifying, emollient and other significant properties to the wool wax alcohols as does cholesterol.
- Still a further object of the invention bearing in mind the important emollient characteristics of wool wax alcohol creams, and possible absorption of certain ingredients into the blood stream, thus possibly upsetting dangerously the maximum cholesterol allowance in the blood stream is to replace cholesterol in wool wax alcohols with another sterol which is nonirritating, non-toxic and non-controversial from a health point of view, yet retaining essentially the same emulsifying, emollient and other desirable properties as unaltered natural wool wax alcohols.
- Yet another object of the invention is to reduce mar kedly the amount of cholesterol present in wool wax alcohols.
- Still another object of this invention is to replace cholesterol in wool wax alcohols, wholly or in part, with a sterol similar in structure, but much less expensive than cholesterol, yet extending to the wool wax alcohols essentially the same, or even enhanced, desirable characteristics as are em bodied in the intact" wool wax alcohols.
- Yet a valuable object of this invention is to improve the economics of cholesterol manufacture, via extraction from wool wax alcohols, by almost doubling the present financial return from wool wax alcohols, and thus enhancing the prospects of cholesterol production on a scale to meet indispensible human and animal health needs and the presently growing demand.
- Still a final object of this invention is to find satisfactory methods for incorporating into spent" wool wax alcohols (wool wax alcohols from which cholesterol has been extracted substantially wholly or in part) a sterol which enhances and/or equals the desirable characteristics hitherto attributed to cholesterol.
- sitosterol is replaced by replacing the cholesterol in wool wax alcohols by Sitosterol" from soybean oil, or from other sources such as Tallol, or sometimes called Tall Oil (from waste paper pulping liquors), cottonseed oil, etc.
- Sitosterol is replaced by replacing the cholesterol in wool wax alcohols by Sitosterol" from soybean oil, or from other sources such as Tallol, or sometimes called Tall Oil (from waste paper pulping liquors), cottonseed oil, etc.
- sitosterol I include B-sitosterol and other naturally occurring products that may be extracted along from soya oil, Tall oil, and cottonseed oil and generally termed sitosterol.
- EXAMPLE I The essentially solvent-free mixture of soaps and wool grease alcohols resulting from the saponification of wool grease, is treated with a suitable solvent, which dissolves the wool grease alcohols and leaves the solid metallic salts of the fatty acids. The latter are separated from the solution by filtration, or centrifuging. The solvent is distilled from the solution of the wool wax alcohols, and the cholesterol is removed from the wool wax alcohols by conventional methods such as those described in Truters' Wool Wax (loc. cit.), pp. -194 (62 references on the Isolation of Cholesterol); J. Th. hackmann, Rec. Trav. Chim. 69, 433 (1950); British Patent 622,725 (1949); H. W. Knol, U.S. Pat. No. 2,536,753 (1951).
- the crude soya, tallol, or cottonseed sitosterols may be separated by methodssuch as are described by P. L. Julian in U.S. Pat. Nos. 2,218,97l (1940); 2,273,045 (I942) and 2,273,046 (1942); also by Overhoff and Ralphmann, Canadian Patent. 519,754 (1955), and Greiner and Fevig, Ind. & Eng. Chem. 53, 949 (1961).
- the crude sitosterols may be refined by crystallization or by separating them from resins, etc., as described in' kg. modified wool wax alcohols, m.p. in the range of 89-90 C.
- EXAMPLE 2 Still another 80 kg. of modified and greatly improved wool wax alcohols, were prepared as follows: A solution of wool wax alcohols, from which the cholesterol had been essentially removed, was concentrated, whereupon an average of 60 percent of the higher melting alcohols crystallized as an almost colorless product. The latter was separated from the supernatant liquors, which liquors on freeing from low-boiling solvent, were subjected to molecular distillation, yielding an almost colorless distillate of relatively lower boiling wool wax alcohols in essentially quantitative yield. This latter fraction was added to the crystals and to this mixture 25 kg. of highly-purified sitosterol was added.
- EXAMPLE4 A 50 g. sample of a solution prepared by dissolving 6 g. modified wool wax alcohols (from Example 1) in 48 g. Protol, USP (white mineral oil of Sonneborn Division, Witco Chemical Company, having a specific gravity at 60 F. of 0.970-0.880, Saybolt viscosity at 100 F. 180-190, and Kinematic viscosity at 37.8 F. 38.6-40.9) was heated to ca. 60 C. To this solution was added water, heated to ca. 60 C., in approximately 10 ml. quantities at a time, while the mixture was beaten in a Sunbeam Mixmaster, Model MMZOOWS, at speed 4. Water was added at a rate so that the previous quantity was absorbed before the next quantity was added.
- Emulsion stands firm several months. The emulsion in Example 4 is rated good.”
- the sterols were isolated from Tall Oil as indicated in U.S. pat. Nos. 2,218,971, 2,273,045 and 2,273,046 and/or U.S. Pat. No. 2,536,753.
- EXAMPLE 5 A 50 g. sample of solution as prepared in Example 4, except originating from modified wool wax alcohols as described in Example 2, was treated as in Example 4. The average total water absorption was 1,153 ml. to form an emulsion of excellent stability.
- EXAMPLE 6 A 50 g. sample of solution as prepared in Example 4, except containing only wool wax alcohols commercially available from Takasago Perfumery Company, Ltd., Japan, m.p. 52 C., was treated as in Example 4. The average total water absorption was 676 ml. to give an emulsion of poor stability.
- EXAMPLE 7 A 50 g. sample of solution as prepared in Example 4, except containing only wool wax alcohols commercially available from Takasago Perfumery Co., Ltd. (but which alcohols 1 had subjected to molecular distillation at 200/25-35 microns in percent yield), m.p. 61 C., was treated as in Example 4. The average total water absorption was 865 ml. to form an emulsion of fair stability.
- EXAMPLE 8 A 50 g. sample of solution was prepared in Example 4, except containing only wool wax alcohols commercially available from Croda, Inc., New York, under the label Hartolan, m.p. 65 C., was treated as in Example 4. The average total water absorption was 993 ml. to give an emulsion of good stability.-
- EXAMPLE 9 A 50 g. sample of solution as prepared in Example 4, except containing only wool wax alcohols commercially available from Croda, Inc., under the label Super Hartolan, m.p. 75 C., was treated as in Example 4. The average total water absorption was 1,187 ml. to form an emulsion of excellent stability.
- EXAMPLE 10 A 50 g. sample of solution as prepared in Example 4, except containing only wool wax alcohols commercially available from Westbrook-Marriner, lnc., Lawrence, Mass. under the label Argowax, Standard, m.p. 64 C., was treated as in Example 4. The average water absorption was 858 ml. to give an emulsion of good stability.
- EXAMPLE 1 1 A 50 g. sample ofsolution as prepared in Example 4, except containing only wool wax alcohols commercially available from Westbrook-Marriner, lnc., under the label Argowax, Distilled, m.p. 73 C., was treated as in Example 4. The average total water absorption was 1,028 ml. to form an emulsion of excellent stability.
- EXAMPLE 12 A 5 g. sample of modified wool wax alcohols (Example 1) was dissolved in 45 g. Carnation, F.F. mineral oil (white mineral oil of Sonneborn Division, Witco Chemical Company, specific gravity at 60 F. 0.835-0.845, Saybolt viscosity at F. 65-75, Kinematic viscosity at 37.8 F. l l.7l4.4). This solution Average was heated to ca. 60 C. and water at 60 C. was added Pg lgf as in Example 1. The water absorption was l,l8l ml.
- the average total water absorption was 0 precipitable steroids.
- This new compositionof matter 1,630 ml. to give an emulsion of excellent stability. removes at least in large part the hazard of possible cholesterol absorption into the blood stream, particu- EXAMPLE 19 larly when such a material may be frequently applied to the skin.
- the resultant product is enhanced 1,803 ml. to afford an emulsion f exc llent stability. by molecular distillation to give a color refinement and A comparison of pertinent characteristics is as folfreedom from resinous or polymeric and/or high-boillows: ing materials.
- sitosterol Thus, under currentconditions, it is.
- the refined composition may represent as high as 60-70 percent of the material subjected to distillation. Since the molecular distillation is an expensive process, particularly for high-boiling and heat sensitive products, this guarantees an economic advantage over present commercially distilled wool wax alcohols.
- a new and useful cosmetic emollient water-absorbing mineral oil-emulsifying pale yellow crystallinelike solid mass composition of matter comprising spent wool wax alcohols which are poor emulsifiers when essentially freed of the cholesterol constituent which imparts emulsion forming ability thereto, and a sufficient quantity of a sterol consisting principally of sitosterol as to bring these spent wool wax alcohols up to the emulsifying capacity of the intact cholesterol-bearing wool wax alcohols.
- a new composition of matter in accordance with claim 1 comprising wool wax alcohols from which cholesterol has been substantially removed and replaced entirely by sitosterol in sufficient quantities to represent substantially the emulsification equivalent of replaced cholesterol.
- sitosterol represents from about 15 percent to about 35 percent of the weight of the wool wax alcohols.
- a new composition according to claim 2 in combination with a mineral oil carrier said composition being characterized therein to absorb up to several hundred times its weight of water, forming stable emulsion, principally of the water-in-oil type, and useful in the production of a wide variety of cosmetic creams and lotions.
- a new composition according to claim 2 in which about 0.01 percent to about 1 percent of an antioxidant has been added.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Birds (AREA)
- Medicinal Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Materials Engineering (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fats And Perfumes (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13702871A | 1971-04-23 | 1971-04-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
US3711611A true US3711611A (en) | 1973-01-16 |
Family
ID=22475492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US00137028A Expired - Lifetime US3711611A (en) | 1971-04-23 | 1971-04-23 | Composition of matter with low cholesterol content and containing wool grease alcohols as major component and method |
Country Status (4)
Country | Link |
---|---|
US (1) | US3711611A (fr) |
BE (1) | BE788507A (fr) |
FR (1) | FR2197959B1 (fr) |
NL (1) | NL7212622A (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5759584A (en) * | 1994-10-28 | 1998-06-02 | Beiersdorf Ag | Method for treating skin afflicted with blemishes or acne with a composition comprising distilled wool wax acids and at least one monoglycerol monocarboxylic acid monoester |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2938656C3 (de) * | 1979-09-25 | 1987-06-19 | Beiersdorf Ag, 2000 Hamburg | Verfahren zur Herstellung von Wollwachsalkoholen und deren Verwendung als Emulgatoren |
FR2568142B1 (fr) * | 1984-07-26 | 1989-11-17 | Oreal | |
ES2366614T3 (es) | 2004-12-06 | 2011-10-21 | SEBAPHARMA GMBH & CO. KG | Composición cosmética o dermatológica en forma de emulsión agua-aceite conteniendo fitosteroles. |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2676149A (en) * | 1951-12-29 | 1954-04-20 | Shell Dev | Stabilized grease composition containing a sterol and a selenium compound |
US2725334A (en) * | 1951-11-20 | 1955-11-29 | American Cholesterol Products | Modified lanolin |
US2900307A (en) * | 1957-07-05 | 1959-08-18 | Colgate Palmolive Co | Clear liquid solubilized lanolin compositions |
US3101300A (en) * | 1960-06-30 | 1963-08-20 | Bristol Myers Co | Clear mineral oil in water emulsion for hair application |
US3272851A (en) * | 1963-07-24 | 1966-09-13 | Malmstrom Chem Corp | Purification of acylated lanolin products |
-
0
- BE BE788507D patent/BE788507A/fr unknown
-
1971
- 1971-04-23 US US00137028A patent/US3711611A/en not_active Expired - Lifetime
-
1972
- 1972-09-06 FR FR7231518A patent/FR2197959B1/fr not_active Expired
- 1972-09-18 NL NL7212622A patent/NL7212622A/xx not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2725334A (en) * | 1951-11-20 | 1955-11-29 | American Cholesterol Products | Modified lanolin |
US2676149A (en) * | 1951-12-29 | 1954-04-20 | Shell Dev | Stabilized grease composition containing a sterol and a selenium compound |
US2900307A (en) * | 1957-07-05 | 1959-08-18 | Colgate Palmolive Co | Clear liquid solubilized lanolin compositions |
US3101300A (en) * | 1960-06-30 | 1963-08-20 | Bristol Myers Co | Clear mineral oil in water emulsion for hair application |
US3272851A (en) * | 1963-07-24 | 1966-09-13 | Malmstrom Chem Corp | Purification of acylated lanolin products |
Non-Patent Citations (3)
Title |
---|
Cockbain et al. Trans. Faraday Soc. 47; 322 330 (1951) Adsorbed Films at Oil Water Interfaces * |
Feldman et al. Biochem. Biophys. Acta 125(1); 136 147 (1966) Phase Distribution of Sterols * |
Karabinos et al. J. Am. Oil Chemists Soc. 31; 136 (1954) Synthesis and Comparative Detergency of Built Polyethenoxy Sitosterols * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5759584A (en) * | 1994-10-28 | 1998-06-02 | Beiersdorf Ag | Method for treating skin afflicted with blemishes or acne with a composition comprising distilled wool wax acids and at least one monoglycerol monocarboxylic acid monoester |
Also Published As
Publication number | Publication date |
---|---|
FR2197959B1 (fr) | 1976-05-21 |
DE2250340B2 (de) | 1977-02-17 |
NL7212622A (fr) | 1974-03-20 |
AU464122A (fr) | 1975-08-14 |
DE2250340A1 (de) | 1974-04-25 |
BE788507A (fr) | 1973-01-02 |
FR2197959A1 (fr) | 1974-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE4228476C2 (de) | Verfahren zum Gewinnen von Tocopherol und/oder Sterin | |
EP0555776A1 (fr) | Procédé de séparation et d'épuration des acides gras et des acides gras alpha-hydroxyliques | |
DE1037621B (de) | Parfuem | |
JPS5824598A (ja) | ステロ−ルまたはその混合物の分離方法 | |
US3711611A (en) | Composition of matter with low cholesterol content and containing wool grease alcohols as major component and method | |
Motiuk | Wool wax alcohols: a review | |
US3821121A (en) | Preparation of wool wax alcohol product of low cholesterol content useful as dispersing and emulsifying agent | |
EP0339382B1 (fr) | Procédé pour désodoriser des mélanges d'esters d'acides gras | |
DE2835445C2 (de) | Verwendung von Estern des Gemisches der Tricyclo-[5.2.1.0↑2↑↑.↑↑6↑]decan-3- und Tricyclo [5.2.1.0↑2↑↑.↑↑6↑]decan-4-carbonsäure als Riechstoffe, sowie diese enthaltende Riechstoffkompositionen | |
DE2756772C2 (fr) | ||
DE2559751C2 (de) | Verwendung einer Spiranverbindung als Riech- bzw. Aromastoff | |
DE2015865A1 (de) | Cyclische Ester und Verwendung (der selben) in der Parfumene | |
EP0684299A2 (fr) | Dihydrofarnesal | |
DE2508060A1 (de) | Cycloaliphatische ungesaettigte ketone als geschmack- und riechstoffe | |
US2347460A (en) | Process for treating fat-soluble vitamin-containing oils | |
Gillespie | Wool wax. A review of its properties, recovery and utilization | |
DE2017208A1 (de) | 4-Methy l-pentanoI-2-crotonat | |
DE3815259A1 (de) | Isomere formyl-trimethylbicyclo(2.2.2)oct-7-ene | |
DE731972C (de) | Verfahren zur Darstellung von d 1-Tocopherolen | |
EP0105157A1 (fr) | Compositions de parfum contenant des spirolactones | |
DE3874377T2 (de) | Aliphatische bicyclische alkohole und ihre anwendung als riechstoffe. | |
DE1617035A1 (de) | Verfahren zur Hydrierung von Glyceridoelen fuer Speisezwecke | |
Cook et al. | 92. The sterols of Calycanthus floridus | |
JPH07238059A (ja) | 新規なラブデノイック酸エチルエステル及びこれを含有する香料組成物 | |
US1037425A (en) | Hair-tonic and method of compounding same. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: FIRST NATIONAL BANK OF CHICAGO THE, TRUSTEE UNDER Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:DIAMOND SHAMROCK CORPORATION A CORP. OF DE;REEL/FRAME:004082/0106 Effective date: 19811201 Owner name: JULIAN, ANNA J. TRUSTEE UNDER THE WILL OF PERCY L. Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:DIAMOND SHAMROCK CORPORATION A CORP. OF DE;REEL/FRAME:004082/0106 Effective date: 19811201 Owner name: BECKER, BENJAMIN M. TRUSTEE UNDER THE WILL OF PERC Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:DIAMOND SHAMROCK CORPORATION A CORP. OF DE;REEL/FRAME:004082/0106 Effective date: 19811201 Owner name: FIRST NATIONAL BANK OF CHICAGO THE, TRUSTEE UNDER Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DIAMOND SHAMROCK CORPORATION A CORP. OF DE;REEL/FRAME:004082/0106 Effective date: 19811201 Owner name: JULIAN, ANNA J. TRUSTEE UNDER THE WILL OF PERCY L. Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DIAMOND SHAMROCK CORPORATION A CORP. OF DE;REEL/FRAME:004082/0106 Effective date: 19811201 Owner name: BECKER, BENJAMIN M. TRUSTEE UNDER THE WILL OF PERC Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DIAMOND SHAMROCK CORPORATION A CORP. OF DE;REEL/FRAME:004082/0106 Effective date: 19811201 |